Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-01-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.843461/full |
| _version_ | 1828132865835008000 |
|---|---|
| author | Brwa Ali Hussein Brwa Ali Hussein Alexander Hallner Alexander Hallner Lovisa Wennström Mats Brune Anna Martner Anna Martner Kristoffer Hellstrand Kristoffer Hellstrand Elin Bernson Elin Bernson Fredrik B. Thorén Fredrik B. Thorén |
| author_facet | Brwa Ali Hussein Brwa Ali Hussein Alexander Hallner Alexander Hallner Lovisa Wennström Mats Brune Anna Martner Anna Martner Kristoffer Hellstrand Kristoffer Hellstrand Elin Bernson Elin Bernson Fredrik B. Thorén Fredrik B. Thorén |
| author_sort | Brwa Ali Hussein |
| collection | DOAJ |
| first_indexed | 2024-04-11T17:09:54Z |
| format | Article |
| id | doaj.art-0a6225aaf7f04aa6bbdf917a321d10fd |
| institution | Directory Open Access Journal |
| issn | 1664-3224 |
| language | English |
| last_indexed | 2024-04-11T17:09:54Z |
| publishDate | 2022-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj.art-0a6225aaf7f04aa6bbdf917a321d10fd2022-12-22T04:12:55ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-01-011210.3389/fimmu.2021.843461843461Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid LeukemiaBrwa Ali Hussein0Brwa Ali Hussein1Alexander Hallner2Alexander Hallner3Lovisa Wennström4Mats Brune5Anna Martner6Anna Martner7Kristoffer Hellstrand8Kristoffer Hellstrand9Elin Bernson10Elin Bernson11Fredrik B. Thorén12Fredrik B. Thorén13Tumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, SwedenDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, SwedenTumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, SwedenDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, SwedenDepartment of Hematology, Institute of Medicine, University of Gothenburg, Gothenburg, SwedenDepartment of Hematology, Institute of Medicine, University of Gothenburg, Gothenburg, SwedenTumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, SwedenDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, SwedenTumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, SwedenDepartment of Infectious Diseases, Institute of Biomedicine, University of Gothenburg, Gothenburg, SwedenTumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, SwedenDepartment of Obstetrics and Gynecology, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, SwedenTumor Immunology (TIMM) Laboratory at Sahlgrenska Center for Cancer Research, University of Gothenburg, Gothenburg, SwedenDepartment of Medical Biochemistry and Cell Biology, Institute of Biomedicine, University of Gothenburg, Gothenburg, Swedenhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.843461/fullNK cell receptorsgene variantssingle nucleotide polymorphismacute myeloid leukemiahistamine/IL-2Re:Mission trial |
| spellingShingle | Brwa Ali Hussein Brwa Ali Hussein Alexander Hallner Alexander Hallner Lovisa Wennström Mats Brune Anna Martner Anna Martner Kristoffer Hellstrand Kristoffer Hellstrand Elin Bernson Elin Bernson Fredrik B. Thorén Fredrik B. Thorén Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia Frontiers in Immunology NK cell receptors gene variants single nucleotide polymorphism acute myeloid leukemia histamine/IL-2 Re:Mission trial |
| title | Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia |
| title_full | Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia |
| title_fullStr | Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia |
| title_full_unstemmed | Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia |
| title_short | Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia |
| title_sort | corrigendum impact of nk cell activating receptor gene variants on receptor expression and outcome of immunotherapy in acute myeloid leukemia |
| topic | NK cell receptors gene variants single nucleotide polymorphism acute myeloid leukemia histamine/IL-2 Re:Mission trial |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2021.843461/full |
| work_keys_str_mv | AT brwaalihussein corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT brwaalihussein corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT alexanderhallner corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT alexanderhallner corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT lovisawennstrom corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT matsbrune corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT annamartner corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT annamartner corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT kristofferhellstrand corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT kristofferhellstrand corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT elinbernson corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT elinbernson corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT fredrikbthoren corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia AT fredrikbthoren corrigendumimpactofnkcellactivatingreceptorgenevariantsonreceptorexpressionandoutcomeofimmunotherapyinacutemyeloidleukemia |